We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+9.08%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
AUM
$663M
AUM Growth
+$70.5M
Cap. Flow
+$41.2M
Cap. Flow %
6.22%
Top 10 Hldgs %
59.59%
Holding
99
New
18
Increased
4
Reduced
2
Closed
7

Sector Composition

Rank Sector Weight
1 Healthcare 26%
2 Industrials 13.45%
3 Miscellaneous 12.78%
4 Consumer Discretionary 11.5%
5 Financials 11.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIBT
51
DELISTED
RiceBran Technologies
RIBT
$1.13M 0.17%
100,000
-70,333
-41% -$707K
VATE icon
52
INNOVATE Corp
VATE
$104M
$1.09M 0.17%
27,480
BKTI icon
53
BK Technologies
BKTI
$274M
$945K 0.14%
+60,000
New +$1.21M
SLGC
54
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$859K 0.13%
+70,100
New +$860K
YEXT icon
55
Yext
YEXT
$693M
$857K 0.13%
60,000
INFI
56
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$748K 0.11%
250,000
ARKOW
57
DELISTED
ARKO Corp Warrant
ARKOW
$663K 0.1%
333,333
LBTYA icon
58
Liberty Global Class A
LBTYA
$3.64B
$624K 0.09%
22,989
ICCC icon
59
ImmuCell
ICCC
$90.3M
$576K 0.09%
+60,607
New +$591K
BATRK icon
60
Atlanta Braves Holdings Series B
BATRK
$3.24B
$575K 0.09%
20,717
FGNA.U
61
DELISTED
FG New America Acquisition Corp. Units, each consisting of one share of Class A common stock and one
FGNA.U
$550K 0.08%
+250,000
New +$2.79M
EQRXW
62
DELISTED
EQRx, Inc. Warrant
EQRXW
$516K 0.08%
+200,000
New +$531K
RTX icon
63
RTX Corp
RTX
$285B
$512K 0.08%
6,000
ISLEW
64
DELISTED
Isleworth Healthcare Acquisition Corporation Warrant
ISLEW
$350K 0.05%
500,000
LHX icon
65
L3Harris
LHX
$48.9B
$346K 0.05%
1,600
LGF.B
66
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$300K 0.05%
16,413
BATRA icon
67
Atlanta Braves Holdings Series A
BATRA
$3.58B
$292K 0.04%
10,356
CARR icon
68
Carrier Global
CARR
$48.5B
$292K 0.04%
6,000
OTIS icon
69
Otis Worldwide
OTIS
$27.3B
$245K 0.04%
3,000
LILAK icon
70
Liberty Latin America Class C
LILAK
$1.66B
$233K 0.04%
18,174
XFOR icon
71
X4 Pharmaceuticals
XFOR
$401M
$232K 0.04%
1,191
PHYS icon
72
Sprott Physical Gold
PHYS
$16B
$176K 0.03%
12,540
QTEK
73
DELISTED
QualTek Services Inc. Class A Common Stock
QTEK
$148K 0.02%
+15,000
New +$147K
AENTW icon
74
Alliance Entertainment Holding Corp Warrants
AENTW
$134K 0.02%
+200,000
New +$108K
BNY
75
Bank of New York Mellon
BNY
$110B
$102K 0.02%
2,000

Similar funds

Bleichroeder LP's Q2 2021 Portfolio in Review

As of Q2 2021, Bleichroeder LP held 99 positions worth $663M, up 12% from $592M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Bleichroeder LP deployed $41.2M of net new capital in Q2 2021, opening 18 new positions and adding to 4 existing holdings. Its largest new stake was Pioneer Merger Corp. Class A Ordinary Share: 2,125,000 shares worth $21.1M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Industrials and Miscellaneous.

On the sell side, the largest reduction was Filana Therapeutics, an estimated $6.7M trimmed.

  • Bleichroeder LP's largest Q2 2021 buy was Pioneer Merger Corp. Class A Ordinary Share: 2,125,000 shares worth $21.1M.
  • Bleichroeder LP added most to Marinus Pharmaceuticals, Inc in Q2 2021, an estimated $3.74M increase.
  • Bleichroeder LP's biggest Q2 2021 reduction was Filana Therapeutics, cutting an estimated $6.7M.
  • Bleichroeder LP fully exited Adara Acquisition Corp Units in Q2 2021, selling an estimated $3.97M.
  • Bleichroeder LP's ten largest holdings make up 60% of its $663M portfolio in Q2 2021.
  • Bleichroeder LP opened 18 new positions and closed 7 in Q2 2021.
  • Bleichroeder LP's portfolio value rose 12% quarter-over-quarter to $663M.

Based on Bleichroeder LP's 13F filing for Q2 2021, filed 16 Aug 2021.